Medigen Vaccine Biologics Corp (高端疫苗) yesterday reported higher neutralizing antibody levels in people who were given its COVID-19 vaccine as a booster after two AstraZeneca doses, the company said.
In a trial of 200 participants who received Medigen’s COVID-19 vaccine, neutralizing antibodies against the Omicron variant of SARS-CoV-2 grew by 5.7 times one month after being administered, Taoyuan General Hospital said.
Medigen said that the results have been submitted to medRxiv, an online platform for researchers to share complete but unpublished papers.
Photo: Chu Pei-hsiung, Taipei Times
Another trial conducted by National Taiwan University Hospital showed that among 45 participants who received three doses of the Medigen vaccine, the level of neutralizing antibodies against the Omicron variant gradually fell, similar to those who received three doses of mRNA COVID-19 vaccines such as those made by Pfizer-BionNTech and Moderna Inc.
“This result indicates that our vaccine, as a booster shot, provided protection against the Omicron variant to some degree,” Medigen said.
The company said that people who have received adenovirus-based vaccines, such as the one made by AstraZeneca, or mRNA-based vaccines could consider taking the Medigen vaccine as a third shot given its safety profile, mild side effects and immunogenicity.
Medigen’s vaccine is a protein subunit vaccine, developed by recombinant technology. It comprises the recombinant spike protein of SARS-CoV-2 as the antigen to help a person’s body recognize the virus if a person becomes infected.
The company said that it would recruit 960 participants for a “mix-and-match” clinical trial in which it plans to test the safety and immunogenicity of different combinations of multiple brands of COVID-19 vaccines.
Medigen has received a subsidy of US$2.3 million from the Coalition for Epidemic Preparedness Innovations, an international foundation, to conduct the trial.
The trial is to be carried out in four hospitals, and recruitment of participants has begun, it said.
As of Sunday, 1.51 million people had received two doses of Medigen’s vaccine, accounting for four percent of 36.17 million who had received two COVID-19 shots, while 112,838 people had chosen the vaccine as booster shot, Centers for Disease Control data showed.
AVOIDING CONFUSION: Passengers are to be able to check in two items of luggage, while the free weight allowance is to be increased to conform with other airlines EVA Airways Corp (長榮航空) yesterday announced that from June 23 it is to adopt a new baggage allowance policy for all passengers with a higher weight limit as it aims to benefit passengers and increase efficiency. The airline currently has a two-system baggage policy: It allows passengers flying to the US and Canada to check in two pieces of baggage with a free weight allowance, while for those flying to Asia, Europe and Oceania there is also a free weight allowance, but no limit on the number of pieces of baggage. From June 23, passengers would be able to check in two
MORE THAN BUZZ: The chip designer said it has received numerous orders from automakers to supply 5G modem chips, as it works to expand beyond smartphones MediaTek Inc (聯發科) yesterday said it would ship the first 5G chips for vehicles to customers in the Asia-Pacific region by the end of the year, as it moves to expand the reach of its 5G chips beyond smartphones. The Hsinchu-based chip designer said it has been developing 5G chips for connected vehicles over the past few years, targeting applications such as telematics and in-vehicle information systems. “We are seeing demand for 5G technology from numerous makers of connected cars, including electric vehicle makers. We have obtained numerous orders from automakers to supply 5G modem chips with highly integrated features,” J.C. Hsu
Qualcomm Inc yesterday said it would maintain its supply chain strategy of sourcing chips from multiple foundry partners, including advanced chips from two major suppliers, to ensure a sufficient chip supply amid the COVID-19 pandemic. Qualcomm is reportedly working with Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) and Samsung Electronics Co on advanced products, such as 4-nanometer chips, for its new flagship 5G chips, the Snapdragon 8+ Gen 1 series. Qualcomm is sourcing chips made by mature technologies from several foundry partners, the company said. Alex Katouzian, general manager of Qualcomm Technologies Inc’s mobile, compute and XR business, told a virtual media briefing that
US DRAM maker Micron Technology Inc is set to install the industry’s most cutting-edge technology — extreme ultraviolet (EUV) lithography equipment — in its facility in Taichung this year, the company said yesterday. In early preparation for the volume production of 1-gamma nanometer node DRAM, “we plan to introduce EUV tools to our Taichung fab later this year,” Micron president and chief executive officer Sanjay Mehrotra said via video at the Computex trade show in Taipei. Gamma refers to the dimension of half the distance between cells in a DRAM chip. Micron is also looking forward to beginning mass production of its
RSS